Jeff Yass’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
181,400
+150,200
+481% +$1.16M ﹤0.01% 6536
2026
Q1
$199K Buy
31,200
+20,900
+203% +$145K ﹤0.01% 11719
2025
Q4
$72.5K Sell
10,300
-38,600
-79% -$233K ﹤0.01% 11610
2025
Q3
$269K Sell
48,900
-228,600
-82% -$1.12M ﹤0.01% 10368
2025
Q2
$1.43M Sell
277,500
-531,500
-66% -$3.18M ﹤0.01% 6562
2025
Q1
$5.39M Sell
809,000
-217,100
-21% -$1.65M ﹤0.01% 3521
2024
Q4
$7.56M Buy
1,026,100
+620,800
+153% +$4.46M ﹤0.01% 2999
2024
Q3
$2.84M Buy
405,300
+286,800
+242% +$1.72M ﹤0.01% 4650
2024
Q2
$582K Buy
118,500
+52,600
+80% +$317K ﹤0.01% 7891
2024
Q1
$407K Sell
65,900
-4,000
-6% -$26.9K ﹤0.01% 8994
2023
Q4
$547K Sell
69,900
-10,300
-13% -$66.4K ﹤0.01% 8438
2023
Q3
$551K Buy
80,200
+55,200
+221% +$447K ﹤0.01% 8005
2023
Q2
$228K Buy
+25,000
New +$208K ﹤0.01% 10005
2022
Q2
Sell
-10,100
Closed -$102K 13485
2022
Q1
$102K Sell
10,100
-14,300
-59% -$126K ﹤0.01% 11898
2021
Q4
$232K Sell
24,400
-23,900
-49% -$253K ﹤0.01% 11119
2021
Q3
$700K Buy
+48,300
New +$930K ﹤0.01% 8509

Other funds holding LFST

Jeff Yass's LFST Position: Q2 2026 in Review

Jeff Yass reduced its Lifestance Health (LFST) stake by 91% in Q2 2026, selling an estimated $10.3M and leaving 127,363 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #7400.

Jeff Yass first reported a position in LFST in Q2 2021 and has held it in 17 quarters since. The position peaked at $9.26M in Q1 2026. 286 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Jeff Yass held 127,363 shares of Lifestance Health worth $1.36M as of Q2 2026.
  • Jeff Yass sold 1,327,029 Lifestance Health shares in Q2 2026, an estimated $10.3M.
  • Lifestance Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7400 holding.
  • Jeff Yass first reported a position in Lifestance Health in Q2 2021 and has held it in 17 quarters since.
  • Jeff Yass's Lifestance Health position peaked at $9.26M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.